Searched for
MOREPEN LABORATORIES SHARES
Morepen to hire 1,000 medical representatives to strengthen formulations bizMorepen Laboratories plans to significantly expand its medical representative team, adding over 1,000 members in the next three years, with...
Morepen Laboratories Q3 Results: Profit dips 10% to Rs 22 crNet revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...
Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...
Morepen Labs jumps 11% on transfer of medical devices biz to subsidiaryAccording to a BSE filing, Morepen Labs will transfer the medical equipment business to a wholly-owned subsidiary by allotment of equity sh...
Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 crIts net revenue stood at Rs 388.31 crore in the quarter under consideration, up 50 per cent against Rs 258.97 crore a year ago, Morepen Lab...
Morepen gets shareholder nod to raise Rs 433 croreMorepen said it plans to utilise the raised capital to expand research and development (R&D) facilities and to set up a new USFDA standard ...
125% jump in a month, 360% in a year; safety rush turns this laggard a multibaggerThe smallcap pharma scrip has been thumping rock and roll over the past few weeks.
Morepen Laboratories posts two-fold jump in Q4 profitThe drug firm's consolidated net profit came in at Rs 26.76 crore for the quarter ended March 31.
Morepen Labs surges 18% in 2 days. Here's whyMorepen Labs, which surged 9.42 per cent on Wednesday, advanced another 7.7 per cent to hit a high of Rs 59.45 in Thursday's trade. This to...
Morepen Labs Q3 results: Net profit rises over two-fold to Rs 24 crConsolidated total revenue of the company stood at Rs 310.26 crore for the quarter under consideration. It was Rs 234.65 crore for the same...
Morepen Labs Q2 results: Net profit jumps over 6-fold to Rs 27crTotal revenue stood at Rs 340.12 crore for the quarter under consideration. It was Rs 216.24 crore for the same period a year ago, it added.
Morepen Labs Q1 results: Net profit jumps over two-fold to Rs 19.36 croreThe company had posted a net profit of Rs 7.65 crore in the corresponding period of previous fiscal, Morepen Laboratories said in a filing ...
Trending stocks: Morepen Laboratories shares slip over 5%A total of 368,301 shares changed hands on the counter till 11:07AM (IST).
Morepen Labs Q4 results: Net profit rises 5% to Rs 11 croreIts consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.
Morepen Labs gets USFDA nod for asthma drugMorepen is the market leader for Montelukast in India with over 50 per cent market share, supplying to almost all major finished dosage man...
Pinfold Overseas acquires 6.42 stake in Morepen LaboratoriesThe company, which already had 2.14 per cent stake in the pharma firm, purchased additional shares through an off-market transaction on Nov...
- Morepen Labs Q1 net loss widens by 29.48 pc to Rs 13.13 crore
Morepen Laboratories today said its net loss widened by 29.48 per cent to Rs 13.13 crore for the quarter ended June 30, 2011 over the same ...
- Morepen Labs in equity deal with Avenue Capital
Morepen Laboratories has signed an agreement with GL India Mauritius III, a subsidiary of Avenue Capital Group, for subscribing 14.99 per c...
- Morepen Lab partly settles debt from banks
Pharmaceutical company Morepen Laboratories on Tuesday said it has issued fresh capital of Rs 103 crore to banks and financial institutions...
- PE investors to buy 40% in Morepen Labs
Rana Talwar’s Sabre Capital, Spinnaker Capital and Deutsche Bank are together acquiring about 40% stake in Morepen Laboratories.